California braces as US withdraws from WHO; state eyes independent disease‑tracking — experts warn of global health security risks
The United States completed its withdrawal from the World Health Organization on Jan. 22, 2026, prompting state leaders and experts to warn that lost data flows, funding gaps and surveillance breaks could threaten global and local health security.
Key takeaways
- U.S. withdrawal effective Jan. 22, 2026: formal one‑year notice ended and U.S. membership, funding and personnel assignments stopped (HHS press release; CDC).
- Administration plan: shift to direct, bilateral public‑health cooperation with other nations rather than WHO coordination (CDC).
- Expert concerns: exit may slow access to early outbreak data, harm vaccine research and weaken global surveillance systems (CIDRAP; ABC News).
Main content
What changed and why
The Trump administration gave formal notice of withdrawal on Jan. 20, 2025, through Executive Order 14155. The WHO requires a 12‑month notice for a member to leave; that period ended Jan. 22, 2026, and the U.S. stopped official membership, governance seats, funding, and assignments of U.S. staff to WHO posts (HHS press release; CDC).
Administration officials argued the WHO mishandled early COVID‑19 signals, delayed emergency declarations, and failed to represent U.S. concerns. Officials cite the WHO COVID‑19 response as a central reason for withdrawal and say the U.S. will form direct partnerships for disease surveillance and public‑health projects (CDC; ABC News).
Financial disputes
The United States historically provided about 20% of WHO’s budget and left unpaid balances that vary by report — commonly cited figures include $133 million, $270 million, or about $278 million covering dues and assessed contributions for 2024–2025. WHO officials have said withdrawal may not be fully resolved until financial obligations are sorted; the executive board and World Health Assembly will review the matter. U.S. officials counter that the WHO Constitution does not bind the U.S. to pay post‑withdrawal or to settle certain assessed fees (ABC7; ABC News; WHO statement).
Expert reaction: surveillance, vaccines and research at risk
Medical and public‑health groups responded strongly. The Infectious Diseases Society of America called the move “shortsighted, misguided, and scientifically reckless,” warning that U.S. removal from WHO mechanisms will hamper early detection of outbreaks and limit data sharing needed for vaccine and treatment development (CIDRAP).
Experts highlighted specific losses, including:
- Access to early outbreak reports and coordinated alerts that often flow through WHO channels.
- Participation in the Global Influenza Surveillance and Response System (GISRS), which helps shape seasonal flu vaccine strain selection.
- Coordination on polio eradication, maternal and child health programs, and multinational research into viral threats (CIDRAP; ABC7).
Legal and diplomatic questions
Some legal scholars argue the president’s unilateral withdrawal exceeds executive authority. Georgetown law professor Lawrence Gostin has said U.S. membership involved congressional action in 1948 and that withdrawal weakens U.S. standing in global health diplomacy. The debate raises questions about authority, oversight and how the U.S. will maintain influence over international health standards without WHO membership (ABC7).
U.S. plan to work bilaterally
Federal officials say the U.S. will expand direct, bilateral public‑health cooperation. The administration argues this allows tailored programs with partner countries and preserves core surveillance functions outside WHO structures. Critics warn bilateral work cannot easily replace multilateral systems that collect and verify early outbreak intelligence across many nations (CDC).
California’s local angle and reporting gaps
California leaders say they want to protect residents from delayed alerts and reduced data flows after the U.S. left WHO. Reports and state statements indicate interest in building independent links to global disease‑tracking networks and strengthening state public‑health ties abroad to protect 39 million residents. However, a review of public records and news reporting shows no detailed federal or WHO documents that list specific California agreements or confirm precise mechanisms the state will use. Research for this report found no public results explicitly documenting California’s planned technical connections to international disease‑tracking systems or formal pledges from foreign partners.
That gap matters because surveillance depends on formal data pipelines, laboratory access, and legal agreements. For California to plug into global networks, state officials would need to secure bilateral lab partnerships, data‑sharing agreements and funding. California public health leaders have the technical expertise and resources to pursue such links, but those steps require time, legal clarity and international cooperation (CDC; WHO).
Implications for The World
Economic impact: The U.S. had been WHO’s largest single donor. Losing that funding shifts budget lines and could slow programs in low‑ and middle‑income countries. Vaccine research and production partnerships may lose U.S. coordination, raising costs for global vaccine development and distribution (HHS press release; CIDRAP).
Political consequences: The exit reshapes global governance. Other countries may view WHO as weakened and re‑align health diplomacy. The U.S. choice to work bilaterally could leave gaps in coordination during cross‑border outbreaks; European and other partners may need new regional mechanisms to share early warnings (WHO statement).
Social effects: Reduced centralized surveillance raises chances that outbreaks are detected later. Delayed information can cost lives and strain health systems. Communities relying on WHO‑supported vaccination and maternal‑child programs may see slower progress if funding and coordination fall (CIDRAP).
Practical applications for health systems
Public health agencies will need new routes to get virus samples, sequence data, and early case reports. Vaccine strain selection for seasonal flu depends on shared data through networks like GISRS; loss of access could hinder vaccine matching. States or countries that act alone will face logistical and legal hurdles to replicate WHO’s role (CDC; CIDRAP).
Global health security risks
Public health experts warn that the U.S. withdrawal raises clear global health security risks: reduced multilateral data sharing and financial strain on WHO programs can slow detection of outbreaks, hamper vaccine development and weaken coordinated responses to threats such as influenza, Ebola and future novel pathogens.
The practical effect could be slower alerts and more localized emergencies with greater chance to spread. State and local leaders, including those in California, face the immediate job of filling information gaps to protect residents — actions that require new agreements, funding and international cooperation that currently lack full public documentation (CIDRAP; CDC; WHO).
Sources and where to read the details
- U.S. Department of Health and Human Services — United States completes WHO withdrawal
- Centers for Disease Control and Prevention — U.S. withdrawal from WHO resources
- World Health Organization — statement on U.S. notification
- ABC7 — reporting on U.S. completion of withdrawal and fiscal questions
- ABC News — coverage of withdrawal and critiques
- CIDRAP — analysis of public health impacts and debt issues
Research note: public records search for California‑specific technical agreements or documented formal pledges from foreign partners returned no explicit public results; further documentation would be needed to confirm planned technical connections to international disease‑tracking systems.
